
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17836387
[patent_doc_number] => 20220273692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => THERAPEUTIC AGENT FOR NERVOUS SYSTEM DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/748553
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748553 | Therapeutic agent for nervous system disease | May 18, 2022 | Issued |
Array
(
[id] => 19556412
[patent_doc_number] => 20240368204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/560481
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560481 | SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF | May 9, 2022 | Pending |
Array
(
[id] => 19345509
[patent_doc_number] => 20240254472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => COMPOSITIONS AND METHODS FOR SIMPLE SAMPLE EXTRACTION
[patent_app_type] => utility
[patent_app_number] => 18/289431
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289431 | COMPOSITIONS AND METHODS FOR SIMPLE SAMPLE EXTRACTION | May 4, 2022 | Pending |
Array
(
[id] => 19263608
[patent_doc_number] => 20240207305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => USE OF CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN
[patent_app_type] => utility
[patent_app_number] => 18/555982
[patent_app_country] => US
[patent_app_date] => 2022-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555982 | Use of chondroitin sulfate for relieving ocular pain | Apr 30, 2022 | Issued |
Array
(
[id] => 20015965
[patent_doc_number] => 20250154187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-15
[patent_title] => COMPOSITIONS AND METHODS RELATED TO MODIFICATION AND DETECTION OF PSEUDOURIDINE AND 5-HYDROXYMETHYLCYTOSINE
[patent_app_type] => utility
[patent_app_number] => 18/556842
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556842 | COMPOSITIONS AND METHODS RELATED TO MODIFICATION AND DETECTION OF PSEUDOURIDINE AND 5-HYDROXYMETHYLCYTOSINE | Apr 26, 2022 | Pending |
Array
(
[id] => 20577274
[patent_doc_number] => 12569509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Method and composition for preventing and treating viral infections
[patent_app_type] => utility
[patent_app_number] => 17/729711
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 72
[patent_no_of_words] => 12032
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729711 | Method and composition for preventing and treating viral infections | Apr 25, 2022 | Issued |
Array
(
[id] => 20207486
[patent_doc_number] => 20250277206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => METHOD FOR EXTRACTING NUCLEIC ACID FROM SAMPLE RICH IN POLYPHENOL AND/OR POLYSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 18/550970
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550970 | METHOD FOR EXTRACTING NUCLEIC ACID FROM SAMPLE RICH IN POLYPHENOL AND/OR POLYSACCHARIDE | Apr 18, 2022 | Pending |
Array
(
[id] => 19187767
[patent_doc_number] => 20240166680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => NUCLEOSIDE ANALOG AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/286416
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 434
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286416 | NUCLEOSIDE ANALOG AND USE THEREOF | Apr 11, 2022 | Pending |
Array
(
[id] => 19140442
[patent_doc_number] => 20240139226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => A COMPOSITION FOR PROMOTING GLP-1 SECRETION
[patent_app_type] => utility
[patent_app_number] => 18/553882
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553882
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553882 | A COMPOSITION FOR PROMOTING GLP-1 SECRETION | Mar 29, 2022 | Pending |
Array
(
[id] => 18483578
[patent_doc_number] => 20230210876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING PENTACYCLIC TRITERPENOIDS
[patent_app_type] => utility
[patent_app_number] => 17/923776
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923776 | Pharmaceutical composition containing pentacyclic triterpenoids | Mar 24, 2022 | Issued |
Array
(
[id] => 19156071
[patent_doc_number] => 20240148778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => GLYCOSIDE INHIBITORS OF YEAST
[patent_app_type] => utility
[patent_app_number] => 18/550349
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550349 | GLYCOSIDE INHIBITORS OF YEAST | Mar 14, 2022 | Pending |
Array
(
[id] => 19832332
[patent_doc_number] => 20250084118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => NOVEL DEALKOXYPHENYLATION REACTION
[patent_app_type] => utility
[patent_app_number] => 18/549797
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549797
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549797 | NOVEL DEALKOXYPHENYLATION REACTION | Mar 10, 2022 | Pending |
Array
(
[id] => 19389494
[patent_doc_number] => 20240279364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => GLYCAN, AND METHOD FOR PRODUCING MEDICINE CONTAINING GLYCAN
[patent_app_type] => utility
[patent_app_number] => 18/549949
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549949
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549949 | GLYCAN, AND METHOD FOR PRODUCING MEDICINE CONTAINING GLYCAN | Mar 10, 2022 | Pending |
Array
(
[id] => 19075295
[patent_doc_number] => 11944638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Ophthalmic solutions
[patent_app_type] => utility
[patent_app_number] => 17/691265
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3985
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691265 | Ophthalmic solutions | Mar 9, 2022 | Issued |
Array
(
[id] => 19187771
[patent_doc_number] => 20240166684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOUNDS FOR ALTERING LEVELS OF ONE OR MORE NKA ALPHA SUBUNITS AND THEIR USE IN TREATING PRION DISEASES OR BRAIN DISEASES ASSOCIATED WITH CELLULAR PRION PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/280977
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280977
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280977 | COMPOUNDS FOR ALTERING LEVELS OF ONE OR MORE NKA ALPHA SUBUNITS AND THEIR USE IN TREATING PRION DISEASES OR BRAIN DISEASES ASSOCIATED WITH CELLULAR PRION PROTEIN | Mar 9, 2022 | Pending |
Array
(
[id] => 19157682
[patent_doc_number] => 20240150389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => MODIFIED GUANINES
[patent_app_type] => utility
[patent_app_number] => 18/277642
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277642 | Modified guanines | Feb 20, 2022 | Issued |
Array
(
[id] => 20116078
[patent_doc_number] => 12365768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Method for deacetylation of biopolymers
[patent_app_type] => utility
[patent_app_number] => 17/676675
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10758
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676675 | Method for deacetylation of biopolymers | Feb 20, 2022 | Issued |
Array
(
[id] => 18043645
[patent_doc_number] => 11517578
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-12-06
[patent_title] => Topical formulations containing erythritol and methods of treating skin conditions
[patent_app_type] => utility
[patent_app_number] => 17/673532
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16340
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673532
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673532 | Topical formulations containing erythritol and methods of treating skin conditions | Feb 15, 2022 | Issued |
Array
(
[id] => 20385424
[patent_doc_number] => 12485133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Inhaled ivermectin
[patent_app_type] => utility
[patent_app_number] => 17/592691
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3812
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592691 | Inhaled ivermectin | Feb 3, 2022 | Issued |
Array
(
[id] => 18683851
[patent_doc_number] => 11779561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Compounds and pharmaceutical uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/590771
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 35417
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590771 | Compounds and pharmaceutical uses thereof | Jan 31, 2022 | Issued |